Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients

Name: Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
Published: 2010
License: Public Domain

University of Leeds · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

multiple-myeloma

multiple myeloma, myeloma, lenalidomide, revlimid, cyclophosphamide, dexamethasone, bortezomib, velcade, vorinostat, zolinza, stem cell, carfilzomib

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 878682
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.